Tonghuo | Vol.02 How Hearing Problems — "Sickness Entering Through the Ears" — Are Driving Us Apart from Our Parents
**03:10** What is hearing impairment? Who are the main groups affected by it?
@daltonventure
以生命科学为根,向硬科技生长
**03:10** What is hearing impairment? Who are the main groups affected by it?
What should investors do to keep up with the changes of this era?
**The life-science and biotechnology revolution unfolding in the world right now — it actually has something to do with you, too.**
Let me tell you stories about life sciences.
The annual Two Sessions have always been a critical barometer for China's economic trajectory and policy direction. This March, when the government elevated "new quality productive forces" to the top of its work agenda, it sparked intense interest and vigorous debate across industries about this buzzword. As one of the most dynamic drivers of technological innovation and industrial transformation—and a strategic emerging industry that lies at the heart of future industrial planning—how should the medical sector translate new quality productive forces into practice? And where will it steer the development and transformation of the life sciences industry?
In a turbulent environment, most investment firms have chosen to play it safe, pulling back on deal activity. Yet in 2023 — widely called a funding winter — Dalton Venture actually picked up its investment pace. How does the firm see 2024 shaping up? At the start of the new year, Sun Qi, founding and managing partner of Dalton Venture, sat down with VBData to share his outlook on healthcare trends for 2024 and his advice for founders.
Rather than burning energy worrying in the face of uncertainty, turn that mental clutter into a trail of action — make concrete the things you want to do and the things you can do.
The Year We Walked Together
Building a company all the way to an IPO is a long and arduous journey. For healthcare startups, the pursuit of technological breakthroughs runs parallel to challenges across nearly every dimension of the business — corporate strategy, commercial model, capital operations, and day-to-day management.
Only non-consensus views can generate excess returns.